Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESTO: Phase 2b study of AZD6793 in adults with moderate to very severe chronic obstructive pulmonary disease
CTR20254553Phase 2Active
- Sponsor
- AstraZeneca
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD6793 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Feb 2026; status: active.
02
Drugs
AZD6793
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20254553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254553.